Terms: = Germ cell tumor AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
77840 results:
1. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
[TBL] [Abstract] [Full Text] [Related]
2. Superficial fibromas with CTNNB1 mutation.
Kuntze A; Meliß RR; Ermert L; Falkenberg KD; Puller AC; Trautmann M; Hartmann W; Wardelmann E
Genes Chromosomes Cancer; 2024 May; 63(5):e23247. PubMed ID: 38757718
[TBL] [Abstract] [Full Text] [Related]
3. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
4. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
5. PRESOLRE: study protocol for a primary school-based, cluster randomised controlled trial of three sun exposure risk prevention strategies on Reunion Island.
Dugast C; Bruneau L; Fianu A; Ferdynus C; Boussaid K; Vuichard J; Duloutre F; Dumez J; Sultan-Bichat N; Bertolotti A
BMJ Open; 2024 May; 14(5):e082045. PubMed ID: 38754877
[TBL] [Abstract] [Full Text] [Related]
6. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
[TBL] [Abstract] [Full Text] [Related]
7. Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.
Bonfiglio F; Lasorsa VA; Aievola V; Cantalupo S; Morini M; Ardito M; Conte M; Fragola M; Eva A; Corrias MV; Iolascon A; Capasso M
HLA; 2024 May; 103(5):e15515. PubMed ID: 38747019
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
Chung DC; Ghaedi M; Warner K; Sayad A; Saibil SD; Bernardini MQ; Clarke BA; Shaw PA; Butler MO; Easson A; Morrissy S; Wang BX; Nguyen L; Ohashi PS; Jacquelot N
Oncoimmunology; 2024; 13(1):2349347. PubMed ID: 38746870
[TBL] [Abstract] [Full Text] [Related]
9. METTL8 links mt-tRNA m
Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic nomogram in middle-aged and elderly patients with chordoma: A SEER-based study.
Ouyang C; Sun Y; Li Y; Jiang M; Nong L; Gao G
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254208. PubMed ID: 38744697
[TBL] [Abstract] [Full Text] [Related]
11. Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma.
Ji Q; McAfee SS; Scoggins M; Holtrop J; Glass JO; Yuan X; Liang J; Li Y; Chiang J; Orr BA; Edwards A; Storment D; Brinkman T; Robinson GW; Gajjar A; Reddick WE; Patay Z; Khan RB; Bag AK
Radiology; 2024 May; 311(2):e232521. PubMed ID: 38742969
[TBL] [Abstract] [Full Text] [Related]
12. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
Chen JQ; Wang JW
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
[No Abstract] [Full Text] [Related]
13. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
Stoyukhina AS
Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
[TBL] [Abstract] [Full Text] [Related]
14. [A rare cause of hypercorticism: ACTH-secreting pheochromocytoma (a case report)].
Rifai K; Toulali F; Iraqi H; Ettaik M; Gharbi MEH
Pan Afr Med J; 2024; 47():88. PubMed ID: 38737225
[TBL] [Abstract] [Full Text] [Related]
15. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.
Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012
[TBL] [Abstract] [Full Text] [Related]
16. Extraneural metastatic ependymoma: distant metastasis to the pleura, lungs, lymph nodes and bone.
Guirguis M; Jiang Z; Cai C; Youssef M
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38729658
[TBL] [Abstract] [Full Text] [Related]
17. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
[TBL] [Abstract] [Full Text] [Related]
18. Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation.
Khandalavala KR; Herberg HA; Kay-Rivest E; Moore LS; Yancey KL; Marinelli JP; Lund-Johansen M; Kosaraju N; Lohse CM; Kutz W; Santa Maria PL; Golfinos JG; Kondziolka D; Carlson ML; Tveiten ØV; Link MJ
Otol Neurotol; 2024 Jun; 45(5):587-593. PubMed ID: 38728563
[TBL] [Abstract] [Full Text] [Related]
19. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract] [Full Text] [Related]
20. Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma cells to TRAIL-Mediated Apoptosis.
Kuranaga Y; Yu B; Osuka S; Zhang H; Devi NS; Bae S; Van Meir EG
Cells; 2024 Apr; 13(9):. PubMed ID: 38727288
[TBL] [Abstract] [Full Text] [Related]
[Next]
